Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
life sciences
4
×
national blog main
amgen
indiana blog main
indiana top stories
san francisco blog main
san francisco top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
detroit blog main
detroit top stories
eli lilly
episodic migraine
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abaloparatide
aimmune therapeutics
alder biopharmaceuticals
allergy
anaphylaxis
What
approval
4
×
developed
4
×
drug
fda
won
amgen
approved
class
late
medicines
migraine
new
nod
pain
starts
agency
aimmune
allergy
amgen’s
announced
awarded
candidates
carries
decision
eli
europe
european
friday
gets
head
headache
heart
immunotherapy
lilly
marketing
marks
medicine
oral
osteoporosis
peanut
Language
unset
Current search:
developed
×
approval
×
" life sciences "
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines